ProShares UltraShort Nasdaq ETF News

(Kitco News) - Gold's solid 6% rally last week off its recent seven-month lows is a major reason why investors need the precious metal in their portfolio.

Wall Street gave a muted performance last week as the S&P 500 and the Nasdaq snapped the prolonged winning streak.

Technical analysis can tell investors a lot about both stocks and ETFs, including when some might have been overbought, or even oversold.

Inverse leveraged biotech ETF and internet ETF traded with an outsized volume on Friday.

We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in develo

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as o

Biotechnology companies have many growth levers and are to be favored for their defensive qualities, in the context of the health and economic crisis.

While everyone's focused on COVID-19, these drugmakers are looking forward to unrelated FDA approvals that could push their stock prices into the clouds.

New York, April 30, 2020 -- Reportlinker.com announces the release of the report "Global Hematologic Malignancies Testing Market: Focus on Product, Disease, Technology, End.

Our gut feeling is that this will not be the last update. US: We are penciling in an 8.0% annualised 2Q20 GDP decline. Europe: Bund yields will likely continue

High drug prices will, again, be a key issue in the 2020 Presidential campaign considering that President Trump has made scant progress on the matter despite much rhetoric.White House press secretary

Following a difficult end to 2018, equity markets delivered very strong returns in 2019. Remarkably, traditional ‘risk-off’ assets such as bonds and precious me